Search In this Thesis
   Search In this Thesis  
العنوان
COMPARISON OF C - REACTIVE PROTEIN LEVELS WITH DELIVERED DOSE OF KT/V IN CHILDREN WITH END-STAGE RENAL DISEASE ON MAINTENANCE HEMODIALYSIS /
المؤلف
Afifi, Tarek Hamed Mohamed.
هيئة الاعداد
باحث / طارق حامد محمد عفيفي
مشرف / غاده محمد المشد
مناقش / السيد إبراهيم الجبالي
مناقش / غاده محمد المشد
الموضوع
Pediatric nephrology. Chronic renal failure. Hemodialysis.
تاريخ النشر
2018.
عدد الصفحات
197 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
طب الأطفال ، الفترة المحيطة بالولادة وصحة الطفل
تاريخ الإجازة
18/1/2018
مكان الإجازة
جامعة المنوفية - كلية الطب - قسم الأطفال
الفهرس
Only 14 pages are availabe for public view

from 195

from 195

Abstract

Objectives: To compare the C-reactive protein (CRP) levels with the delivered dose of dialysis in terms of index of hemodialysis adequacy (Kt/V) in patients undergoing maintenance hemodialysis (HD).
Background: According to different studies, the target Kt/V should be 1.2 per session, while weekly Kt/V should be 4.5 for thrice-weekly HD patients to maintain adequate HD.
Methods: This is a comparative, cross-sectional survey study. Patients who fulfilled the inclusion and exclusion criteria were enrolled in the present study. The delivered dose of HD, Kt/V was assessed by online clearance module (OCM) in Fresenius machines at the end of every session of dialysis and the weekly Kt/V was determined by adding all the three Kt/V values. On the other hand, serum CRP was determined after each session of HD. Both weekly Kt/V and CRP values were entered in a pre-designed proforma.
Results: Of 30 patients on maintenance HD, high serum CRP level (>6 mg/dL) was found in 9 patients. When the Kt/V was compared with the CRP level, there was a negative correlation between the two parameters (r = -0.4, P < 0.001). Low Kt/V means dialysis inadequacy, which is associated with CKD state, resulting in high CRP levels.
Conclusion: Low Kt/V means dialysis inadequacy, and is associated with chronic inflammatory state resulting in high CRP levels. To reduce the rate of morbidity and mortality, we concluded that the quality of life of dialysis patients can be improved by offering an adequate dose of HD reflected by Kt/V ≥4.5/week in all patients with ESRD